نشانگر زیستی سرطان (Persian Wikipedia)

Analysis of information sources in references of the Wikipedia article "نشانگر زیستی سرطان" in Persian language version.

refsWebsite

Global rank Persian rank

88nih.gov

4^th place

5^th place

66doi.org

2^nd place

13worldcat.org

5^th place

12^th place

9archive.org

6^th place

9^th place

6harvard.edu

18^th place

50^th place

5web.archive.org

1^st place

2zenodo.org

621^st place

2,080^th place

1mlo-online.com

low place

1sciencedirect.com

149^th place

190^th place

1cancer.gov

1,684^th place

533^rd place

1researchadvocacy.org

low place

1cshl.edu

low place

1oxfordjournals.org

1,389^th place

783^rd place

1medscape.com

719^th place

248^th place

1time.com

61^st place

101^st place

1ugent.be

3,695^th place

low place

1fda.gov

447^th place

382^nd place

1cancer.org

3,680^th place

1,286^th place

1singularityhub.com

low place

1oup.com

485^th place

806^th place

archive.org

Calzone, Kathleen A. (2012). "Genetic Biomarkers of Cancer Risk". Seminars in Oncology Nursing. 28 (2): 122–128. doi:10.1016/j.soncn.2012.03.007. PMID 22542320.
Leong, PP; Rezai, B; Koch, WM; Reed, A; Eisele, D; Lee, DJ; Sidransky, D; Jen, J; Westra, WH (Jul 1, 1998). "Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma". Journal of the National Cancer Institute. 90 (13): 972–7. doi:10.1093/jnci/90.13.972. PMID 9665144.
Kuukasjärvi, T; Kononen, J; Helin, H; Holli, K; Isola, J (September 1996). "Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy". Journal of Clinical Oncology. 14 (9): 2584–9. doi:10.1200/jco.1996.14.9.2584. PMID 8823339.
Harris, L; Fritsche, H; Mennel, R; Norton, L; Ravdin, P; Taube, S; Somerfield, MR; Hayes, DF; Bast RC, Jr (Nov 20, 2007). "American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer". Journal of Clinical Oncology. 25 (33): 5287–312. doi:10.1200/JCO.2007.14.2364. PMID 17954709.
Herbst, RS; Prager, D; Hermann, R; Fehrenbacher, L; Johnson, BE; Sandler, A; Kris, MG; Tran, HT; Klein, P (Sep 1, 2005). "TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer". Journal of Clinical Oncology. 23 (25): 5892–9. doi:10.1200/JCO.2005.02.840. PMID 16043829.
Sawyers CL (April 2008). "The cancer biomarker problem". Nature. 452 (7187): 548–52. Bibcode:2008Natur.452..548S. doi:10.1038/nature06913. PMID 18385728.
Gonzalez RS, Carlson G, Page AJ, Cohen C (July 2011). "Gastrointestinal stromal tumor markers in cutaneous melanomas: relationship to prognostic factors and outcome". American Journal of Clinical Pathology. 136 (1): 74–80. doi:10.1309/AJCP9KHD7DCHWLMO. PMID 21685034.
Duffy MJ, Crown J (November 2008). "A personalized approach to cancer treatment: how biomarkers can help". Clinical Chemistry. 54 (11): 1770–9. doi:10.1373/clinchem.2008.110056. PMID 18801934.
Bartels CL, Tsongalis GJ (April 2009). "MicroRNAs: novel biomarkers for human cancer". Clinical Chemistry. 55 (4): 623–31. doi:10.1373/clinchem.2008.112805. PMID 19246618.

cancer.gov

"biomarker". NCI Dictionary of Cancer Terms. National Cancer Institute. 2011-02-02.

cancer.org

"Tumor Markers Fact Sheet" (PDF). American Cancer Society. Archived from the original (PDF) on 5 November 2012. Retrieved 7 April 2021.

cshl.edu

repository.cshl.edu

Lynch, TJ; Bell, DW; Sordella, R; Gurubhagavatula, S; Okimoto, RA; Brannigan, BW; Harris, PL; Haserlat, SM; Supko, JG (May 20, 2004). "Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib" (PDF). The New England Journal of Medicine. 350 (21): 2129–39. doi:10.1056/NEJMoa040938. PMID 15118073. Archived from the original (PDF) on 21 July 2018. Retrieved 7 April 2021.

doi.org

Calzone, Kathleen A. (2012). "Genetic Biomarkers of Cancer Risk". Seminars in Oncology Nursing. 28 (2): 122–128. doi:10.1016/j.soncn.2012.03.007. PMID 22542320.
Herceg, Zdenko; Hainaut, Pierre (2007-06-01). "Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis". Molecular Oncology (به انگلیسی). 1 (1): 26–41. doi:10.1016/j.molonc.2007.01.004. ISSN 1878-0261. PMC 5543860. PMID 19383285.
Li, Danni; Chan, Daniel W. (2014-04-01). "Proteomic cancer biomarkers from discovery to approval: it's worth the effort". Expert Review of Proteomics. 11 (2): 135–136. doi:10.1586/14789450.2014.897614. ISSN 1478-9450. PMC 4079106. PMID 24646122.
Aizpurua-Olaizola, O.; Toraño, J. Sastre; Falcon-Perez, J.M.; Williams, C.; Reichardt, N.; Boons, G. -J. (2018). "Mass spectrometry for glycan biomarker discovery". TrAC Trends in Analytical Chemistry. 100: 7–14. doi:10.1016/j.trac.2017.12.015.
Mishra, Alok; Verma, Mukesh (2010). "Cancer Biomarkers: Are We Ready for the Prime Time?". Cancers. 2 (1): 190–208. doi:10.3390/cancers2010190. PMC 3827599. PMID 24281040.
Behne, Tara; Copur, M. Sitki (1 January 2012). "Biomarkers for Hepatocellular Carcinoma". International Journal of Hepatology. 2012: 859076. doi:10.1155/2012/859076. PMC 3357951. PMID 22655201.
Musolino, A; Bella, MA; Bortesi, B; Michiara, M; Naldi, N; Zanelli, P; Capelletti, M; Pezzuolo, D; Camisa, R (June 2007). "BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: a population-based study". Breast. 16 (3): 280–92. doi:10.1016/j.breast.2006.12.003. PMID 17257844. {{cite journal}}: |hdl-access= requires |hdl= (help)
Dienstmann, R; Tabernero, J (March 2011). "BRAF as a target for cancer therapy". Anti-Cancer Agents in Medicinal Chemistry. 11 (3): 285–95. doi:10.2174/187152011795347469. PMID 21426297.
Orphanos, G; Kountourakis, P (2012). "Targeting the HER2 receptor in metastatic breast cancer". Hematology/Oncology and Stem Cell Therapy. 5 (3): 127–37. doi:10.5144/1658-3876.2012.127. PMID 23095788.
DePrimo, S. E.; Huang, X.; Blackstein, M. E.; Garrett, C. R.; Harmon, C. S.; Schoffski, P.; Shah, M. H.; Verweij, J.; Baum, C. M. (8 September 2009). "Circulating Levels of Soluble KIT Serve as a Biomarker for Clinical Outcome in Gastrointestinal Stromal Tumor Patients Receiving Sunitinib following Imatinib Failure". Clinical Cancer Research. 15 (18): 5869–5877. doi:10.1158/1078-0432.CCR-08-2480. PMC 3500590. PMID 19737953.
Kruijff, S; Hoekstra, HJ (April 2012). "The current status of S-100B as a biomarker in melanoma". European Journal of Surgical Oncology. 38 (4): 281–5. doi:10.1016/j.ejso.2011.12.005. PMID 22240030.
Ludwig, JA; Weinstein, JN (November 2005). "Biomarkers in cancer staging, prognosis and treatment selection". Nature Reviews Cancer. 5 (11): 845–56. doi:10.1038/nrc1739. PMID 16239904.
Wang, Qing; Raghothama Chaerkady (December 2010). "Mutant proteins as cancer-specific biomarkers". Proceedings of the National Academy of Sciences. 108 (6): 2444–2449. Bibcode:2011PNAS..108.2444W. doi:10.1073/pnas.1019203108. PMC 3038743. PMID 21248225.
Li, Xuanying; Ye, Mengsha; Zhang, Weiying; Tan, Duo; Jaffrezic-Renault, Nicole; Yang, Xu; Guo, Zhenzhong (2019-02-01). "Liquid biopsy of circulating tumor DNA and biosensor applications". Biosensors and Bioelectronics (به انگلیسی). 126: 596–607. doi:10.1016/j.bios.2018.11.037. ISSN 0956-5663. PMID 30502682.
Verma, M; Manne, U (October 2006). "Genetic and epigenetic biomarkers in cancer diagnosis and identifying high risk populations". Critical Reviews in Oncology/Hematology. 60 (1): 9–18. doi:10.1016/j.critrevonc.2006.04.002. PMID 16829121.
Leong, PP; Rezai, B; Koch, WM; Reed, A; Eisele, D; Lee, DJ; Sidransky, D; Jen, J; Westra, WH (Jul 1, 1998). "Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma". Journal of the National Cancer Institute. 90 (13): 972–7. doi:10.1093/jnci/90.13.972. PMID 9665144.
Lapin, Morten; Oltedal, Satu; Tjensvoll, Kjersti; Buhl, Tove; Smaaland, Rune; Garresori, Herish; Javle, Milind; Glenjen, Nils Idar; Abelseth, Bente Kristin (2018-11-06). "Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer". Journal of Translational Medicine (به انگلیسی). 16 (1): 300. doi:10.1186/s12967-018-1677-2. ISSN 1479-5876. PMC 6218961. PMID 30400802.
Dragani, TA; Matarese, V; Colombo, F (2020). "Biomarkers for Early Cancer Diagnosis: Prospects for Success through the Lens of Tumor Genetics". BioEssays. 42 (4): e1900122. doi:10.1002/bies.201900122. PMID 32128843.
Terpos E, Dimopoulos MA, Shrivastava V, et al. (March 2010). "High levels of serum TIMP-1 correlate with advanced disease and predict for poor survival in patients with multiple myeloma treated with novel agents". Leukemia Research. 34 (3): 399–402. doi:10.1016/j.leukres.2009.08.035. PMID 19781774.
Kuukasjärvi, T; Kononen, J; Helin, H; Holli, K; Isola, J (September 1996). "Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy". Journal of Clinical Oncology. 14 (9): 2584–9. doi:10.1200/jco.1996.14.9.2584. PMID 8823339.
Harris, L; Fritsche, H; Mennel, R; Norton, L; Ravdin, P; Taube, S; Somerfield, MR; Hayes, DF; Bast RC, Jr (Nov 20, 2007). "American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer". Journal of Clinical Oncology. 25 (33): 5287–312. doi:10.1200/JCO.2007.14.2364. PMID 17954709.
Kröger, N; Milde-Langosch, K; Riethdorf, S; Schmoor, C; Schumacher, M; Zander, AR; Löning, T (Jan 1, 2006). "Prognostic and predictive effects of immunohistochemical factors in high-risk primary breast cancer patients". Clinical Cancer Research. 12 (1): 159–68. doi:10.1158/1078-0432.CCR-05-1340. PMID 16397038.
Yoo, C; Ryu, MH; Ryoo, BY; Beck, MY; Kang, YK (Apr 17, 2013). "Efficacy, safety, and pharmacokinetics of imatinib dose escalation to 800 mg/day in patients with advanced gastrointestinal stromal tumors". Investigational New Drugs. 31 (5): 1367–74. doi:10.1007/s10637-013-9961-8. PMID 23591629.
Demetri, GD; van Oosterom, AT; Garrett, CR; Blackstein, ME; Shah, MH; Verweij, J; McArthur, G; Judson, IR; Heinrich, MC (Oct 14, 2006). "Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial". Lancet. 368 (9544): 1329–38. doi:10.1016/S0140-6736(06)69446-4. PMID 17046465.
Herbst, RS; Prager, D; Hermann, R; Fehrenbacher, L; Johnson, BE; Sandler, A; Kris, MG; Tran, HT; Klein, P (Sep 1, 2005). "TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer". Journal of Clinical Oncology. 23 (25): 5892–9. doi:10.1200/JCO.2005.02.840. PMID 16043829.
Lynch, TJ; Bell, DW; Sordella, R; Gurubhagavatula, S; Okimoto, RA; Brannigan, BW; Harris, PL; Haserlat, SM; Supko, JG (May 20, 2004). "Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib" (PDF). The New England Journal of Medicine. 350 (21): 2129–39. doi:10.1056/NEJMoa040938. PMID 15118073. Archived from the original (PDF) on 21 July 2018. Retrieved 7 April 2021.
Sawyers CL (April 2008). "The cancer biomarker problem". Nature. 452 (7187): 548–52. Bibcode:2008Natur.452..548S. doi:10.1038/nature06913. PMID 18385728.
Karas-Kuzelicki, N; Mlinaric-Rascan, I (August 2009). "Individualization of thiopurine therapy: thiopurine S-methyltransferase and beyond". Pharmacogenomics. 10 (8): 1309–22. doi:10.2217/pgs.09.78. PMID 19663675.
Relling MV, Hancock ML, Rivera GK, et al. (December 1999). "Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus". Journal of the National Cancer Institute. 91 (23): 2001–8. doi:10.1093/jnci/91.23.2001. PMID 10580024.
Schneider, John; Manpreet K Sidhu; Cynthia Doucet; Noemi Kiss; Robert L Ohsfeldt; Donald Chalfin (2012). "Economics of Cancer Biomarkers". Personalized Medicine. 9 (8): 829–837. doi:10.2217/pme.12.87. PMID 29776231.
Henze, G; Dummer, R; Joller-Jemelka, HI; Böni, R; Burg, G (1997). "Serum S100--a marker for disease monitoring in metastatic melanoma". Dermatology. 194 (3): 208–12. doi:10.1159/000246103. PMID 9187834.
Harpio, R; Einarsson, R (July 2004). "S100 proteins as cancer biomarkers with focus on S100B in malignant melanoma". Clinical Biochemistry. 37 (7): 512–8. doi:10.1016/j.clinbiochem.2004.05.012. PMID 15234232.
Lamond, NW; Skedgel, C; Younis, T (April 2013). "Is the 21-gene recurrence score a cost-effective assay in endocrine-sensitive node-negative breast cancer?". Expert Review of Pharmacoeconomics & Outcomes Research. 13 (2): 243–50. doi:10.1586/erp.13.4. PMID 23570435.
Biroschak, JR; Schwartz, GF; Palazzo, JP; Toll, AD; Brill, KL; Jaslow, RJ; Lee, SY (May 2013). "Impact of Oncotype DX on Treatment Decisions in ER-Positive, Node-Negative Breast Cancer with Histologic Correlation". The Breast Journal. 19 (3): 269–75. doi:10.1111/tbj.12099. PMID 23614365.
Moen, MD; McKeage, K; Plosker, GL; Siddiqui, MA (2007). "Imatinib: a review of its use in chronic myeloid leukaemia". Drugs. 67 (2): 299–320. doi:10.2165/00003495-200767020-00010. PMID 17284091.
Price, C; McDonnell, D (February 1991). "Effects of niobium filtration and constant potential on the sensitometric responses of dental radiographic films". Dentomaxillofacial Radiology. 20 (1): 11–6. doi:10.1259/dmfr.20.1.1884846. PMID 1884846.
Lu, CY; Tsai, HL; Uen, YH; Hu, HM; Chen, CW; Cheng, TL; Lin, SR; Wang, JY (Mar 5, 2013). "Circulating tumor cells as a surrogate marker for determining clinical outcome to mFOLFOX chemotherapy in patients with stage III colon cancer". British Journal of Cancer. 108 (4): 791–7. doi:10.1038/bjc.2012.595. PMC 3590657. PMID 23422758.
Balic, M; Williams, A; Lin, H; Datar, R; Cote, RJ (2013). "Circulating tumor cells: from bench to bedside". Annual Review of Medicine. 64: 31–44. doi:10.1146/annurev-med-050311-163404. PMC 3809995. PMID 23092385.
Madhavan, D; Zucknick, M; Wallwiener, M; Cuk, K; Modugno, C; Scharpff, M; Schott, S; Heil, J; Turchinovich, A (Nov 1, 2012). "Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancer". Clinical Cancer Research. 18 (21): 5972–82. doi:10.1158/1078-0432.CCR-12-1407. PMID 22952344.
Redova, M; Sana, J; Slaby, O (March 2013). "Circulating miRNAs as new blood-based biomarkers for solid cancers". Future Oncology. 9 (3): 387–402. doi:10.2217/fon.12.192. PMID 23469974.
Joosse, SA; Pantel, K (Jan 1, 2013). "Biologic challenges in the detection of circulating tumor cells". Cancer Research. 73 (1): 8–11. doi:10.1158/0008-5472.CAN-12-3422. PMID 23271724.
Hou, HW; Warkiani, ME; Khoo, BL; Li, ZR; Soo, RA; Tan, DS; Lim, WT; Han, J; Bhagat, AA (2013). "Isolation and retrieval of circulating tumor cells using centrifugal forces". Scientific Reports. 3: 1259. Bibcode:2013NatSR...3E1259H. doi:10.1038/srep01259. PMC 3569917. PMID 23405273.
Dhondt, Bert; De Bleser, Elise; Claeys, Tom; Buelens, Sarah; Lumen, Nicolaas; Vandesompele, Jo; Beckers, Anneleen; Fonteyne, Valerie; Van der Eecken, Kim (21 December 2018). "Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready for prime time". World Journal of Urology. 37 (12): 2557–2564. doi:10.1007/s00345-018-2609-8. PMID 30578441.
Gonzalez RS, Carlson G, Page AJ, Cohen C (July 2011). "Gastrointestinal stromal tumor markers in cutaneous melanomas: relationship to prognostic factors and outcome". American Journal of Clinical Pathology. 136 (1): 74–80. doi:10.1309/AJCP9KHD7DCHWLMO. PMID 21685034.
Tam CS, Otero-Palacios J, Abruzzo LV, et al. (April 2008). "Chronic lymphocytic leukaemia CD20 expression is dependent on the genetic subtype: a study of quantitative flow cytometry and fluorescent in-situ hybridization in 510 patients". British Journal of Haematology. 141 (1): 36–40. doi:10.1111/j.1365-2141.2008.07012.x. PMID 18324964.
Zhang M, Yao Z, Patel H, et al. (May 2007). "Effective therapy of murine models of human leukemia and lymphoma with radiolabeled anti-CD30 antibody, HeFi-1". Proceedings of the National Academy of Sciences of the United States of America. 104 (20): 8444–8. Bibcode:2007PNAS..104.8444Z. doi:10.1073/pnas.0702496104. PMC 1895969. PMID 17488826.
Yamada Y, Sanchez-Aguilera A, Brandt EB, et al. (September 2008). "FIP1L1/PDGFRalpha synergizes with SCF to induce systemic mastocytosis in a murine model of chronic eosinophilic leukemia/hypereosinophilic syndrome". Blood. 112 (6): 2500–7. doi:10.1182/blood-2007-11-126268. PMID 18539901.
Nimer SD (May 2008). "Myelodysplastic syndromes". Blood. 111 (10): 4841–51. doi:10.1182/blood-2007-08-078139. PMID 18467609.
Ottmann O, Dombret H, Martinelli G, et al. (October 2007). "Dasatinib induces rapid hematologic and cytogenetic responses in adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia with resistance or intolerance to imatinib: interim results of a phase 2 study". Blood. 110 (7): 2309–15. doi:10.1182/blood-2007-02-073528. PMID 17496201.
Boulos N, Mulder HL, Calabrese CR, et al. (March 2011). "Chemotherapeutic agents circumvent emergence of dasatinib-resistant BCR-ABL kinase mutations in a precise mouse model of Philadelphia chromosome-positive acute lymphoblastic leukemia". Blood. 117 (13): 3585–95. doi:10.1182/blood-2010-08-301267. PMC 3072880. PMID 21263154.
O'Connell PA, Madureira PA, Berman JN, Liwski RS, Waisman DM (April 2011). "Regulation of S100A10 by the PML-RAR-α oncoprotein". Blood. 117 (15): 4095–105. doi:10.1182/blood-2010-07-298851. PMID 21310922.
Duffy MJ, Crown J (November 2008). "A personalized approach to cancer treatment: how biomarkers can help". Clinical Chemistry. 54 (11): 1770–9. doi:10.1373/clinchem.2008.110056. PMID 18801934.
Ribrag V, Koscielny S, Casasnovas O, et al. (April 2009). "Pharmacogenetic study in Hodgkin lymphomas reveals the impact of UGT1A1 polymorphisms on patient prognosis". Blood. 113 (14): 3307–13. doi:10.1182/blood-2008-03-148874. PMID 18768784.
Li Y, Ye X, Liu J, Zha J, Pei L (January 2011). "Evaluation of EML4-ALK fusion proteins in non-small cell lung cancer using small molecule inhibitors". Neoplasia. 13 (1): 1–11. doi:10.1593/neo.101120. PMC 3022423. PMID 21245935.
Pao W, Girard N (February 2011). "New driver mutations in non-small-cell lung cancer". Lancet Oncology. 12 (2): 175–80. doi:10.1016/S1470-2045(10)70087-5. PMID 21277552.
Gupta, Digant; Lis, Christopher G. (2009-10-09). "Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literature". Journal of Ovarian Research. 2 (1): 13. doi:10.1186/1757-2215-2-13. ISSN 1757-2215. PMC 2764643. PMID 19818123.
Bartels CL, Tsongalis GJ (April 2009). "MicroRNAs: novel biomarkers for human cancer". Clinical Chemistry. 55 (4): 623–31. doi:10.1373/clinchem.2008.112805. PMID 19246618.
Paulson, Kelly G.; Lewis, Christopher W.; Redman, Mary W.; Simonson, William T.; Lisberg, Aaron; Ritter, Deborah; Morishima, Chihiro; Hutchinson, Kathleen; Mudgistratova, Lola (2017). "Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study". Cancer. 123 (8): 1464–1474. doi:10.1002/cncr.30475. PMC 5384867. PMID 27925665.
Proctor, M J; McMillan, D C; Morrison, D S; Fletcher, C D; Horgan, P G; Clarke, S J (2012-07-24). "A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer". British Journal of Cancer. 107 (4): 695–699. doi:10.1038/bjc.2012.292. ISSN 0007-0920. PMC 3419948. PMID 22828611.
Liu, Man; Xing, Lu-Qi (2017-06-07). "Basic fibroblast growth factor as a potential biomarker for diagnosing malignant tumor metastasis in women". Oncology Letters. 14 (2): 1561–1567. doi:10.3892/ol.2017.6335. ISSN 1792-1074. PMC 5529833. PMID 28789380.
Fürstenberger, Gregor; Senn, Hans-Jörg (May 2002). "Insulin-like growth factors and cancer". The Lancet Oncology. 3 (5): 298–302. doi:10.1016/s1470-2045(02)00731-3. ISSN 1470-2045. PMID 12067807.
Yu, Herbert; Rohan, Thomas (2000-09-20). "Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression". JNCI: Journal of the National Cancer Institute (به انگلیسی). 92 (18): 1472–1489. doi:10.1093/jnci/92.18.1472. ISSN 0027-8874. PMID 10995803.
Vano, Yann-Alexandre; Oudard, Stéphane; By, Marie-Agnès; Têtu, Pauline; Thibault, Constance; Aboudagga, Hail; Scotté, Florian; Elaidi, Reza (2018-04-06). "Optimal cut-off for neutrophil-to-lymphocyte ratio: Fact or Fantasy? A prospective cohort study in metastatic cancer patients". PLOS ONE. 13 (4): e0195042. Bibcode:2018PLoSO..1395042V. doi:10.1371/journal.pone.0195042. ISSN 1932-6203. PMC 5889159. PMID 29624591.
Liu, Man; Xing, Lu-Qi (2017-08-01). "Basic fibroblast growth factor as a potential biomarker for diagnosing malignant tumor metastasis in women". Oncology Letters. 14 (2): 1561–1567. doi:10.3892/ol.2017.6335. ISSN 1792-1074. PMC 5529833. PMID 28789380.
Torrente-Rodríguez, Rebeca M.; Ruiz-Valdepeñas Montiel, Víctor; Campuzano, Susana; Pedrero, María; Farchado, Meryem; Vargas, Eva; Manuel de Villena, F. Javier; Garranzo-Asensio, María; Barderas, Rodrigo (2017-04-04). "Electrochemical sensor for rapid determination of fibroblast growth factor receptor 4 in raw cancer cell lysates". PLOS ONE. 12 (4): e0175056. Bibcode:2017PLoSO..1275056T. doi:10.1371/journal.pone.0175056. ISSN 1932-6203. PMC 5380347. PMID 28376106.
Denduluri, Sahitya K.; Idowu, Olumuyiwa; Wang, Zhongliang; Liao, Zhan; Yan, Zhengjian; Mohammed, Maryam K.; Ye, Jixing; Wei, Qiang; Wang, Jing (March 2015). "Insulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance". Genes & Diseases. 2 (1): 13–25. doi:10.1016/j.gendis.2014.10.004. ISSN 2352-3042. PMC 4431759. PMID 25984556.

fda.gov

"Table of Pharmacogenomic Biomarkers in Drug Labels". U.S Food and Drug Administration.

harvard.edu

ui.adsabs.harvard.edu

Wang, Qing; Raghothama Chaerkady (December 2010). "Mutant proteins as cancer-specific biomarkers". Proceedings of the National Academy of Sciences. 108 (6): 2444–2449. Bibcode:2011PNAS..108.2444W. doi:10.1073/pnas.1019203108. PMC 3038743. PMID 21248225.
Sawyers CL (April 2008). "The cancer biomarker problem". Nature. 452 (7187): 548–52. Bibcode:2008Natur.452..548S. doi:10.1038/nature06913. PMID 18385728.
Hou, HW; Warkiani, ME; Khoo, BL; Li, ZR; Soo, RA; Tan, DS; Lim, WT; Han, J; Bhagat, AA (2013). "Isolation and retrieval of circulating tumor cells using centrifugal forces". Scientific Reports. 3: 1259. Bibcode:2013NatSR...3E1259H. doi:10.1038/srep01259. PMC 3569917. PMID 23405273.
Zhang M, Yao Z, Patel H, et al. (May 2007). "Effective therapy of murine models of human leukemia and lymphoma with radiolabeled anti-CD30 antibody, HeFi-1". Proceedings of the National Academy of Sciences of the United States of America. 104 (20): 8444–8. Bibcode:2007PNAS..104.8444Z. doi:10.1073/pnas.0702496104. PMC 1895969. PMID 17488826.
Vano, Yann-Alexandre; Oudard, Stéphane; By, Marie-Agnès; Têtu, Pauline; Thibault, Constance; Aboudagga, Hail; Scotté, Florian; Elaidi, Reza (2018-04-06). "Optimal cut-off for neutrophil-to-lymphocyte ratio: Fact or Fantasy? A prospective cohort study in metastatic cancer patients". PLOS ONE. 13 (4): e0195042. Bibcode:2018PLoSO..1395042V. doi:10.1371/journal.pone.0195042. ISSN 1932-6203. PMC 5889159. PMID 29624591.
Torrente-Rodríguez, Rebeca M.; Ruiz-Valdepeñas Montiel, Víctor; Campuzano, Susana; Pedrero, María; Farchado, Meryem; Vargas, Eva; Manuel de Villena, F. Javier; Garranzo-Asensio, María; Barderas, Rodrigo (2017-04-04). "Electrochemical sensor for rapid determination of fibroblast growth factor receptor 4 in raw cancer cell lysates". PLOS ONE. 12 (4): e0175056. Bibcode:2017PLoSO..1275056T. doi:10.1371/journal.pone.0175056. ISSN 1932-6203. PMC 5380347. PMID 28376106.

medscape.com

Schneider, John; Manpreet K Sidhu; Cynthia Doucet; Noemi Kiss; Robert L Ohsfeldt; Donald Chalfin (2012). "Economics of Cancer Biomarkers". Personalized Medicine. 9 (8): 829–837. doi:10.2217/pme.12.87. PMID 29776231.

mlo-online.com

Rhea, Jeanne; Ross J. Molinaro (March 2011). "Cancer Biomarkers: Surviving the journey from bench to bedside". Medical Laboratory Observer. Archived from the original on 14 October 2013. Retrieved 26 April 2013.

nih.gov

pubmed.ncbi.nlm.nih.gov

Calzone, Kathleen A. (2012). "Genetic Biomarkers of Cancer Risk". Seminars in Oncology Nursing. 28 (2): 122–128. doi:10.1016/j.soncn.2012.03.007. PMID 22542320.
Herceg, Zdenko; Hainaut, Pierre (2007-06-01). "Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis". Molecular Oncology (به انگلیسی). 1 (1): 26–41. doi:10.1016/j.molonc.2007.01.004. ISSN 1878-0261. PMC 5543860. PMID 19383285.
Li, Danni; Chan, Daniel W. (2014-04-01). "Proteomic cancer biomarkers from discovery to approval: it's worth the effort". Expert Review of Proteomics. 11 (2): 135–136. doi:10.1586/14789450.2014.897614. ISSN 1478-9450. PMC 4079106. PMID 24646122.
Mishra, Alok; Verma, Mukesh (2010). "Cancer Biomarkers: Are We Ready for the Prime Time?". Cancers. 2 (1): 190–208. doi:10.3390/cancers2010190. PMC 3827599. PMID 24281040.
Behne, Tara; Copur, M. Sitki (1 January 2012). "Biomarkers for Hepatocellular Carcinoma". International Journal of Hepatology. 2012: 859076. doi:10.1155/2012/859076. PMC 3357951. PMID 22655201.
Musolino, A; Bella, MA; Bortesi, B; Michiara, M; Naldi, N; Zanelli, P; Capelletti, M; Pezzuolo, D; Camisa, R (June 2007). "BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: a population-based study". Breast. 16 (3): 280–92. doi:10.1016/j.breast.2006.12.003. PMID 17257844. {{cite journal}}: |hdl-access= requires |hdl= (help)
Dienstmann, R; Tabernero, J (March 2011). "BRAF as a target for cancer therapy". Anti-Cancer Agents in Medicinal Chemistry. 11 (3): 285–95. doi:10.2174/187152011795347469. PMID 21426297.
Orphanos, G; Kountourakis, P (2012). "Targeting the HER2 receptor in metastatic breast cancer". Hematology/Oncology and Stem Cell Therapy. 5 (3): 127–37. doi:10.5144/1658-3876.2012.127. PMID 23095788.
DePrimo, S. E.; Huang, X.; Blackstein, M. E.; Garrett, C. R.; Harmon, C. S.; Schoffski, P.; Shah, M. H.; Verweij, J.; Baum, C. M. (8 September 2009). "Circulating Levels of Soluble KIT Serve as a Biomarker for Clinical Outcome in Gastrointestinal Stromal Tumor Patients Receiving Sunitinib following Imatinib Failure". Clinical Cancer Research. 15 (18): 5869–5877. doi:10.1158/1078-0432.CCR-08-2480. PMC 3500590. PMID 19737953.
Bantis, A; Grammaticos, P (Sep–Dec 2012). "Prostatic specific antigen and bone scan in the diagnosis and follow-up of prostate cancer. Can diagnostic significance of PSA be increased?". Hellenic Journal of Nuclear Medicine. 15 (3): 241–6. PMID 23227460.
Kruijff, S; Hoekstra, HJ (April 2012). "The current status of S-100B as a biomarker in melanoma". European Journal of Surgical Oncology. 38 (4): 281–5. doi:10.1016/j.ejso.2011.12.005. PMID 22240030.
Ludwig, JA; Weinstein, JN (November 2005). "Biomarkers in cancer staging, prognosis and treatment selection". Nature Reviews Cancer. 5 (11): 845–56. doi:10.1038/nrc1739. PMID 16239904.
Wang, Qing; Raghothama Chaerkady (December 2010). "Mutant proteins as cancer-specific biomarkers". Proceedings of the National Academy of Sciences. 108 (6): 2444–2449. Bibcode:2011PNAS..108.2444W. doi:10.1073/pnas.1019203108. PMC 3038743. PMID 21248225.
Li, Xuanying; Ye, Mengsha; Zhang, Weiying; Tan, Duo; Jaffrezic-Renault, Nicole; Yang, Xu; Guo, Zhenzhong (2019-02-01). "Liquid biopsy of circulating tumor DNA and biosensor applications". Biosensors and Bioelectronics (به انگلیسی). 126: 596–607. doi:10.1016/j.bios.2018.11.037. ISSN 0956-5663. PMID 30502682.
Verma, M; Manne, U (October 2006). "Genetic and epigenetic biomarkers in cancer diagnosis and identifying high risk populations". Critical Reviews in Oncology/Hematology. 60 (1): 9–18. doi:10.1016/j.critrevonc.2006.04.002. PMID 16829121.
Leong, PP; Rezai, B; Koch, WM; Reed, A; Eisele, D; Lee, DJ; Sidransky, D; Jen, J; Westra, WH (Jul 1, 1998). "Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma". Journal of the National Cancer Institute. 90 (13): 972–7. doi:10.1093/jnci/90.13.972. PMID 9665144.
Lapin, Morten; Oltedal, Satu; Tjensvoll, Kjersti; Buhl, Tove; Smaaland, Rune; Garresori, Herish; Javle, Milind; Glenjen, Nils Idar; Abelseth, Bente Kristin (2018-11-06). "Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer". Journal of Translational Medicine (به انگلیسی). 16 (1): 300. doi:10.1186/s12967-018-1677-2. ISSN 1479-5876. PMC 6218961. PMID 30400802.
Dragani, TA; Matarese, V; Colombo, F (2020). "Biomarkers for Early Cancer Diagnosis: Prospects for Success through the Lens of Tumor Genetics". BioEssays. 42 (4): e1900122. doi:10.1002/bies.201900122. PMID 32128843.
Terpos E, Dimopoulos MA, Shrivastava V, et al. (March 2010). "High levels of serum TIMP-1 correlate with advanced disease and predict for poor survival in patients with multiple myeloma treated with novel agents". Leukemia Research. 34 (3): 399–402. doi:10.1016/j.leukres.2009.08.035. PMID 19781774.
Kuukasjärvi, T; Kononen, J; Helin, H; Holli, K; Isola, J (September 1996). "Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy". Journal of Clinical Oncology. 14 (9): 2584–9. doi:10.1200/jco.1996.14.9.2584. PMID 8823339.
Harris, L; Fritsche, H; Mennel, R; Norton, L; Ravdin, P; Taube, S; Somerfield, MR; Hayes, DF; Bast RC, Jr (Nov 20, 2007). "American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer". Journal of Clinical Oncology. 25 (33): 5287–312. doi:10.1200/JCO.2007.14.2364. PMID 17954709.
Kröger, N; Milde-Langosch, K; Riethdorf, S; Schmoor, C; Schumacher, M; Zander, AR; Löning, T (Jan 1, 2006). "Prognostic and predictive effects of immunohistochemical factors in high-risk primary breast cancer patients". Clinical Cancer Research. 12 (1): 159–68. doi:10.1158/1078-0432.CCR-05-1340. PMID 16397038.
Vrbic, S; Pejcic, I; Filipovic, S; Kocic, B; Vrbic, M (Jan–Mar 2013). "Current and future anti-HER2 therapy in breast cancer". Journal of the Balkan Union of Oncology. 18 (1): 4–16. PMID 23613383.
Yoo, C; Ryu, MH; Ryoo, BY; Beck, MY; Kang, YK (Apr 17, 2013). "Efficacy, safety, and pharmacokinetics of imatinib dose escalation to 800 mg/day in patients with advanced gastrointestinal stromal tumors". Investigational New Drugs. 31 (5): 1367–74. doi:10.1007/s10637-013-9961-8. PMID 23591629.
Demetri, GD; van Oosterom, AT; Garrett, CR; Blackstein, ME; Shah, MH; Verweij, J; McArthur, G; Judson, IR; Heinrich, MC (Oct 14, 2006). "Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial". Lancet. 368 (9544): 1329–38. doi:10.1016/S0140-6736(06)69446-4. PMID 17046465.
Herbst, RS; Prager, D; Hermann, R; Fehrenbacher, L; Johnson, BE; Sandler, A; Kris, MG; Tran, HT; Klein, P (Sep 1, 2005). "TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer". Journal of Clinical Oncology. 23 (25): 5892–9. doi:10.1200/JCO.2005.02.840. PMID 16043829.
Lynch, TJ; Bell, DW; Sordella, R; Gurubhagavatula, S; Okimoto, RA; Brannigan, BW; Harris, PL; Haserlat, SM; Supko, JG (May 20, 2004). "Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib" (PDF). The New England Journal of Medicine. 350 (21): 2129–39. doi:10.1056/NEJMoa040938. PMID 15118073. Archived from the original (PDF) on 21 July 2018. Retrieved 7 April 2021.
Sawyers CL (April 2008). "The cancer biomarker problem". Nature. 452 (7187): 548–52. Bibcode:2008Natur.452..548S. doi:10.1038/nature06913. PMID 18385728.
Karas-Kuzelicki, N; Mlinaric-Rascan, I (August 2009). "Individualization of thiopurine therapy: thiopurine S-methyltransferase and beyond". Pharmacogenomics. 10 (8): 1309–22. doi:10.2217/pgs.09.78. PMID 19663675.
Relling MV, Hancock ML, Rivera GK, et al. (December 1999). "Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus". Journal of the National Cancer Institute. 91 (23): 2001–8. doi:10.1093/jnci/91.23.2001. PMID 10580024.
Schneider, John; Manpreet K Sidhu; Cynthia Doucet; Noemi Kiss; Robert L Ohsfeldt; Donald Chalfin (2012). "Economics of Cancer Biomarkers". Personalized Medicine. 9 (8): 829–837. doi:10.2217/pme.12.87. PMID 29776231.
Henze, G; Dummer, R; Joller-Jemelka, HI; Böni, R; Burg, G (1997). "Serum S100--a marker for disease monitoring in metastatic melanoma". Dermatology. 194 (3): 208–12. doi:10.1159/000246103. PMID 9187834.
Harpio, R; Einarsson, R (July 2004). "S100 proteins as cancer biomarkers with focus on S100B in malignant melanoma". Clinical Biochemistry. 37 (7): 512–8. doi:10.1016/j.clinbiochem.2004.05.012. PMID 15234232.
Lamond, NW; Skedgel, C; Younis, T (April 2013). "Is the 21-gene recurrence score a cost-effective assay in endocrine-sensitive node-negative breast cancer?". Expert Review of Pharmacoeconomics & Outcomes Research. 13 (2): 243–50. doi:10.1586/erp.13.4. PMID 23570435.
Biroschak, JR; Schwartz, GF; Palazzo, JP; Toll, AD; Brill, KL; Jaslow, RJ; Lee, SY (May 2013). "Impact of Oncotype DX on Treatment Decisions in ER-Positive, Node-Negative Breast Cancer with Histologic Correlation". The Breast Journal. 19 (3): 269–75. doi:10.1111/tbj.12099. PMID 23614365.
Moen, MD; McKeage, K; Plosker, GL; Siddiqui, MA (2007). "Imatinib: a review of its use in chronic myeloid leukaemia". Drugs. 67 (2): 299–320. doi:10.2165/00003495-200767020-00010. PMID 17284091.
Price, C; McDonnell, D (February 1991). "Effects of niobium filtration and constant potential on the sensitometric responses of dental radiographic films". Dentomaxillofacial Radiology. 20 (1): 11–6. doi:10.1259/dmfr.20.1.1884846. PMID 1884846.
Lu, CY; Tsai, HL; Uen, YH; Hu, HM; Chen, CW; Cheng, TL; Lin, SR; Wang, JY (Mar 5, 2013). "Circulating tumor cells as a surrogate marker for determining clinical outcome to mFOLFOX chemotherapy in patients with stage III colon cancer". British Journal of Cancer. 108 (4): 791–7. doi:10.1038/bjc.2012.595. PMC 3590657. PMID 23422758.
Balic, M; Williams, A; Lin, H; Datar, R; Cote, RJ (2013). "Circulating tumor cells: from bench to bedside". Annual Review of Medicine. 64: 31–44. doi:10.1146/annurev-med-050311-163404. PMC 3809995. PMID 23092385.
Madhavan, D; Zucknick, M; Wallwiener, M; Cuk, K; Modugno, C; Scharpff, M; Schott, S; Heil, J; Turchinovich, A (Nov 1, 2012). "Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancer". Clinical Cancer Research. 18 (21): 5972–82. doi:10.1158/1078-0432.CCR-12-1407. PMID 22952344.
Redova, M; Sana, J; Slaby, O (March 2013). "Circulating miRNAs as new blood-based biomarkers for solid cancers". Future Oncology. 9 (3): 387–402. doi:10.2217/fon.12.192. PMID 23469974.
Joosse, SA; Pantel, K (Jan 1, 2013). "Biologic challenges in the detection of circulating tumor cells". Cancer Research. 73 (1): 8–11. doi:10.1158/0008-5472.CAN-12-3422. PMID 23271724.
Hou, HW; Warkiani, ME; Khoo, BL; Li, ZR; Soo, RA; Tan, DS; Lim, WT; Han, J; Bhagat, AA (2013). "Isolation and retrieval of circulating tumor cells using centrifugal forces". Scientific Reports. 3: 1259. Bibcode:2013NatSR...3E1259H. doi:10.1038/srep01259. PMC 3569917. PMID 23405273.
Dhondt, Bert; De Bleser, Elise; Claeys, Tom; Buelens, Sarah; Lumen, Nicolaas; Vandesompele, Jo; Beckers, Anneleen; Fonteyne, Valerie; Van der Eecken, Kim (21 December 2018). "Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready for prime time". World Journal of Urology. 37 (12): 2557–2564. doi:10.1007/s00345-018-2609-8. PMID 30578441.
Gonzalez RS, Carlson G, Page AJ, Cohen C (July 2011). "Gastrointestinal stromal tumor markers in cutaneous melanomas: relationship to prognostic factors and outcome". American Journal of Clinical Pathology. 136 (1): 74–80. doi:10.1309/AJCP9KHD7DCHWLMO. PMID 21685034.
Tam CS, Otero-Palacios J, Abruzzo LV, et al. (April 2008). "Chronic lymphocytic leukaemia CD20 expression is dependent on the genetic subtype: a study of quantitative flow cytometry and fluorescent in-situ hybridization in 510 patients". British Journal of Haematology. 141 (1): 36–40. doi:10.1111/j.1365-2141.2008.07012.x. PMID 18324964.
Zhang M, Yao Z, Patel H, et al. (May 2007). "Effective therapy of murine models of human leukemia and lymphoma with radiolabeled anti-CD30 antibody, HeFi-1". Proceedings of the National Academy of Sciences of the United States of America. 104 (20): 8444–8. Bibcode:2007PNAS..104.8444Z. doi:10.1073/pnas.0702496104. PMC 1895969. PMID 17488826.
Yamada Y, Sanchez-Aguilera A, Brandt EB, et al. (September 2008). "FIP1L1/PDGFRalpha synergizes with SCF to induce systemic mastocytosis in a murine model of chronic eosinophilic leukemia/hypereosinophilic syndrome". Blood. 112 (6): 2500–7. doi:10.1182/blood-2007-11-126268. PMID 18539901.
Nimer SD (May 2008). "Myelodysplastic syndromes". Blood. 111 (10): 4841–51. doi:10.1182/blood-2007-08-078139. PMID 18467609.
Ottmann O, Dombret H, Martinelli G, et al. (October 2007). "Dasatinib induces rapid hematologic and cytogenetic responses in adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia with resistance or intolerance to imatinib: interim results of a phase 2 study". Blood. 110 (7): 2309–15. doi:10.1182/blood-2007-02-073528. PMID 17496201.
Boulos N, Mulder HL, Calabrese CR, et al. (March 2011). "Chemotherapeutic agents circumvent emergence of dasatinib-resistant BCR-ABL kinase mutations in a precise mouse model of Philadelphia chromosome-positive acute lymphoblastic leukemia". Blood. 117 (13): 3585–95. doi:10.1182/blood-2010-08-301267. PMC 3072880. PMID 21263154.
O'Connell PA, Madureira PA, Berman JN, Liwski RS, Waisman DM (April 2011). "Regulation of S100A10 by the PML-RAR-α oncoprotein". Blood. 117 (15): 4095–105. doi:10.1182/blood-2010-07-298851. PMID 21310922.
Duffy MJ, Crown J (November 2008). "A personalized approach to cancer treatment: how biomarkers can help". Clinical Chemistry. 54 (11): 1770–9. doi:10.1373/clinchem.2008.110056. PMID 18801934.
Ribrag V, Koscielny S, Casasnovas O, et al. (April 2009). "Pharmacogenetic study in Hodgkin lymphomas reveals the impact of UGT1A1 polymorphisms on patient prognosis". Blood. 113 (14): 3307–13. doi:10.1182/blood-2008-03-148874. PMID 18768784.
Li Y, Ye X, Liu J, Zha J, Pei L (January 2011). "Evaluation of EML4-ALK fusion proteins in non-small cell lung cancer using small molecule inhibitors". Neoplasia. 13 (1): 1–11. doi:10.1593/neo.101120. PMC 3022423. PMID 21245935.
Pao W, Girard N (February 2011). "New driver mutations in non-small-cell lung cancer". Lancet Oncology. 12 (2): 175–80. doi:10.1016/S1470-2045(10)70087-5. PMID 21277552.
Gupta, Digant; Lis, Christopher G. (2009-10-09). "Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literature". Journal of Ovarian Research. 2 (1): 13. doi:10.1186/1757-2215-2-13. ISSN 1757-2215. PMC 2764643. PMID 19818123.
Bartels CL, Tsongalis GJ (April 2009). "MicroRNAs: novel biomarkers for human cancer". Clinical Chemistry. 55 (4): 623–31. doi:10.1373/clinchem.2008.112805. PMID 19246618.
Paulson, Kelly G.; Lewis, Christopher W.; Redman, Mary W.; Simonson, William T.; Lisberg, Aaron; Ritter, Deborah; Morishima, Chihiro; Hutchinson, Kathleen; Mudgistratova, Lola (2017). "Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study". Cancer. 123 (8): 1464–1474. doi:10.1002/cncr.30475. PMC 5384867. PMID 27925665.
Proctor, M J; McMillan, D C; Morrison, D S; Fletcher, C D; Horgan, P G; Clarke, S J (2012-07-24). "A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer". British Journal of Cancer. 107 (4): 695–699. doi:10.1038/bjc.2012.292. ISSN 0007-0920. PMC 3419948. PMID 22828611.
Liu, Man; Xing, Lu-Qi (2017-06-07). "Basic fibroblast growth factor as a potential biomarker for diagnosing malignant tumor metastasis in women". Oncology Letters. 14 (2): 1561–1567. doi:10.3892/ol.2017.6335. ISSN 1792-1074. PMC 5529833. PMID 28789380.
Fürstenberger, Gregor; Senn, Hans-Jörg (May 2002). "Insulin-like growth factors and cancer". The Lancet Oncology. 3 (5): 298–302. doi:10.1016/s1470-2045(02)00731-3. ISSN 1470-2045. PMID 12067807.
Yu, Herbert; Rohan, Thomas (2000-09-20). "Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression". JNCI: Journal of the National Cancer Institute (به انگلیسی). 92 (18): 1472–1489. doi:10.1093/jnci/92.18.1472. ISSN 0027-8874. PMID 10995803.
Vano, Yann-Alexandre; Oudard, Stéphane; By, Marie-Agnès; Têtu, Pauline; Thibault, Constance; Aboudagga, Hail; Scotté, Florian; Elaidi, Reza (2018-04-06). "Optimal cut-off for neutrophil-to-lymphocyte ratio: Fact or Fantasy? A prospective cohort study in metastatic cancer patients". PLOS ONE. 13 (4): e0195042. Bibcode:2018PLoSO..1395042V. doi:10.1371/journal.pone.0195042. ISSN 1932-6203. PMC 5889159. PMID 29624591.
Liu, Man; Xing, Lu-Qi (2017-08-01). "Basic fibroblast growth factor as a potential biomarker for diagnosing malignant tumor metastasis in women". Oncology Letters. 14 (2): 1561–1567. doi:10.3892/ol.2017.6335. ISSN 1792-1074. PMC 5529833. PMID 28789380.
Torrente-Rodríguez, Rebeca M.; Ruiz-Valdepeñas Montiel, Víctor; Campuzano, Susana; Pedrero, María; Farchado, Meryem; Vargas, Eva; Manuel de Villena, F. Javier; Garranzo-Asensio, María; Barderas, Rodrigo (2017-04-04). "Electrochemical sensor for rapid determination of fibroblast growth factor receptor 4 in raw cancer cell lysates". PLOS ONE. 12 (4): e0175056. Bibcode:2017PLoSO..1275056T. doi:10.1371/journal.pone.0175056. ISSN 1932-6203. PMC 5380347. PMID 28376106.
Denduluri, Sahitya K.; Idowu, Olumuyiwa; Wang, Zhongliang; Liao, Zhan; Yan, Zhengjian; Mohammed, Maryam K.; Ye, Jixing; Wei, Qiang; Wang, Jing (March 2015). "Insulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance". Genes & Diseases. 2 (1): 13–25. doi:10.1016/j.gendis.2014.10.004. ISSN 2352-3042. PMC 4431759. PMID 25984556.

ncbi.nlm.nih.gov

Herceg, Zdenko; Hainaut, Pierre (2007-06-01). "Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis". Molecular Oncology (به انگلیسی). 1 (1): 26–41. doi:10.1016/j.molonc.2007.01.004. ISSN 1878-0261. PMC 5543860. PMID 19383285.
Li, Danni; Chan, Daniel W. (2014-04-01). "Proteomic cancer biomarkers from discovery to approval: it's worth the effort". Expert Review of Proteomics. 11 (2): 135–136. doi:10.1586/14789450.2014.897614. ISSN 1478-9450. PMC 4079106. PMID 24646122.
Mishra, Alok; Verma, Mukesh (2010). "Cancer Biomarkers: Are We Ready for the Prime Time?". Cancers. 2 (1): 190–208. doi:10.3390/cancers2010190. PMC 3827599. PMID 24281040.
Behne, Tara; Copur, M. Sitki (1 January 2012). "Biomarkers for Hepatocellular Carcinoma". International Journal of Hepatology. 2012: 859076. doi:10.1155/2012/859076. PMC 3357951. PMID 22655201.
DePrimo, S. E.; Huang, X.; Blackstein, M. E.; Garrett, C. R.; Harmon, C. S.; Schoffski, P.; Shah, M. H.; Verweij, J.; Baum, C. M. (8 September 2009). "Circulating Levels of Soluble KIT Serve as a Biomarker for Clinical Outcome in Gastrointestinal Stromal Tumor Patients Receiving Sunitinib following Imatinib Failure". Clinical Cancer Research. 15 (18): 5869–5877. doi:10.1158/1078-0432.CCR-08-2480. PMC 3500590. PMID 19737953.
Wang, Qing; Raghothama Chaerkady (December 2010). "Mutant proteins as cancer-specific biomarkers". Proceedings of the National Academy of Sciences. 108 (6): 2444–2449. Bibcode:2011PNAS..108.2444W. doi:10.1073/pnas.1019203108. PMC 3038743. PMID 21248225.
Lapin, Morten; Oltedal, Satu; Tjensvoll, Kjersti; Buhl, Tove; Smaaland, Rune; Garresori, Herish; Javle, Milind; Glenjen, Nils Idar; Abelseth, Bente Kristin (2018-11-06). "Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer". Journal of Translational Medicine (به انگلیسی). 16 (1): 300. doi:10.1186/s12967-018-1677-2. ISSN 1479-5876. PMC 6218961. PMID 30400802.
Lu, CY; Tsai, HL; Uen, YH; Hu, HM; Chen, CW; Cheng, TL; Lin, SR; Wang, JY (Mar 5, 2013). "Circulating tumor cells as a surrogate marker for determining clinical outcome to mFOLFOX chemotherapy in patients with stage III colon cancer". British Journal of Cancer. 108 (4): 791–7. doi:10.1038/bjc.2012.595. PMC 3590657. PMID 23422758.
Balic, M; Williams, A; Lin, H; Datar, R; Cote, RJ (2013). "Circulating tumor cells: from bench to bedside". Annual Review of Medicine. 64: 31–44. doi:10.1146/annurev-med-050311-163404. PMC 3809995. PMID 23092385.
Hou, HW; Warkiani, ME; Khoo, BL; Li, ZR; Soo, RA; Tan, DS; Lim, WT; Han, J; Bhagat, AA (2013). "Isolation and retrieval of circulating tumor cells using centrifugal forces". Scientific Reports. 3: 1259. Bibcode:2013NatSR...3E1259H. doi:10.1038/srep01259. PMC 3569917. PMID 23405273.
Zhang M, Yao Z, Patel H, et al. (May 2007). "Effective therapy of murine models of human leukemia and lymphoma with radiolabeled anti-CD30 antibody, HeFi-1". Proceedings of the National Academy of Sciences of the United States of America. 104 (20): 8444–8. Bibcode:2007PNAS..104.8444Z. doi:10.1073/pnas.0702496104. PMC 1895969. PMID 17488826.
Boulos N, Mulder HL, Calabrese CR, et al. (March 2011). "Chemotherapeutic agents circumvent emergence of dasatinib-resistant BCR-ABL kinase mutations in a precise mouse model of Philadelphia chromosome-positive acute lymphoblastic leukemia". Blood. 117 (13): 3585–95. doi:10.1182/blood-2010-08-301267. PMC 3072880. PMID 21263154.
Li Y, Ye X, Liu J, Zha J, Pei L (January 2011). "Evaluation of EML4-ALK fusion proteins in non-small cell lung cancer using small molecule inhibitors". Neoplasia. 13 (1): 1–11. doi:10.1593/neo.101120. PMC 3022423. PMID 21245935.
Gupta, Digant; Lis, Christopher G. (2009-10-09). "Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literature". Journal of Ovarian Research. 2 (1): 13. doi:10.1186/1757-2215-2-13. ISSN 1757-2215. PMC 2764643. PMID 19818123.
Paulson, Kelly G.; Lewis, Christopher W.; Redman, Mary W.; Simonson, William T.; Lisberg, Aaron; Ritter, Deborah; Morishima, Chihiro; Hutchinson, Kathleen; Mudgistratova, Lola (2017). "Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study". Cancer. 123 (8): 1464–1474. doi:10.1002/cncr.30475. PMC 5384867. PMID 27925665.
Proctor, M J; McMillan, D C; Morrison, D S; Fletcher, C D; Horgan, P G; Clarke, S J (2012-07-24). "A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer". British Journal of Cancer. 107 (4): 695–699. doi:10.1038/bjc.2012.292. ISSN 0007-0920. PMC 3419948. PMID 22828611.
Liu, Man; Xing, Lu-Qi (2017-06-07). "Basic fibroblast growth factor as a potential biomarker for diagnosing malignant tumor metastasis in women". Oncology Letters. 14 (2): 1561–1567. doi:10.3892/ol.2017.6335. ISSN 1792-1074. PMC 5529833. PMID 28789380.
Vano, Yann-Alexandre; Oudard, Stéphane; By, Marie-Agnès; Têtu, Pauline; Thibault, Constance; Aboudagga, Hail; Scotté, Florian; Elaidi, Reza (2018-04-06). "Optimal cut-off for neutrophil-to-lymphocyte ratio: Fact or Fantasy? A prospective cohort study in metastatic cancer patients". PLOS ONE. 13 (4): e0195042. Bibcode:2018PLoSO..1395042V. doi:10.1371/journal.pone.0195042. ISSN 1932-6203. PMC 5889159. PMID 29624591.
Liu, Man; Xing, Lu-Qi (2017-08-01). "Basic fibroblast growth factor as a potential biomarker for diagnosing malignant tumor metastasis in women". Oncology Letters. 14 (2): 1561–1567. doi:10.3892/ol.2017.6335. ISSN 1792-1074. PMC 5529833. PMID 28789380.
Torrente-Rodríguez, Rebeca M.; Ruiz-Valdepeñas Montiel, Víctor; Campuzano, Susana; Pedrero, María; Farchado, Meryem; Vargas, Eva; Manuel de Villena, F. Javier; Garranzo-Asensio, María; Barderas, Rodrigo (2017-04-04). "Electrochemical sensor for rapid determination of fibroblast growth factor receptor 4 in raw cancer cell lysates". PLOS ONE. 12 (4): e0175056. Bibcode:2017PLoSO..1275056T. doi:10.1371/journal.pone.0175056. ISSN 1932-6203. PMC 5380347. PMID 28376106.
Denduluri, Sahitya K.; Idowu, Olumuyiwa; Wang, Zhongliang; Liao, Zhan; Yan, Zhengjian; Mohammed, Maryam K.; Ye, Jixing; Wei, Qiang; Wang, Jing (March 2015). "Insulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance". Genes & Diseases. 2 (1): 13–25. doi:10.1016/j.gendis.2014.10.004. ISSN 2352-3042. PMC 4431759. PMID 25984556.

oup.com

academic.oup.com

Yu, Herbert; Rohan, Thomas (2000-09-20). "Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression". JNCI: Journal of the National Cancer Institute (به انگلیسی). 92 (18): 1472–1489. doi:10.1093/jnci/92.18.1472. ISSN 0027-8874. PMID 10995803.

oxfordjournals.org

jnci.oxfordjournals.org

Relling MV, Hancock ML, Rivera GK, et al. (December 1999). "Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus". Journal of the National Cancer Institute. 91 (23): 2001–8. doi:10.1093/jnci/91.23.2001. PMID 10580024.

researchadvocacy.org

"Biomarkers in Cancer: An Introductory Guide for Advocates" (PDF). Research Advocacy Network. 2010. Archived from the original (PDF) on 2013-10-29. Retrieved 26 April 2013.

sciencedirect.com

Li, Xuanying; Ye, Mengsha; Zhang, Weiying; Tan, Duo; Jaffrezic-Renault, Nicole; Yang, Xu; Guo, Zhenzhong (2019-02-01). "Liquid biopsy of circulating tumor DNA and biosensor applications". Biosensors and Bioelectronics (به انگلیسی). 126: 596–607. doi:10.1016/j.bios.2018.11.037. ISSN 0956-5663. PMID 30502682.

singularityhub.com

Hewes, Arlington (October 2, 2014). "Promising Method for Detecting Pancreatic Cancer Years Before Traditional Diagnosis". Singularity HUB. Retrieved 2016-04-22.

time.com

Lemonick, Michael; Alice Park (May 28, 2001). "New Hope for Cancer". Time Magazine. Archived from the original on 25 April 2013. Retrieved 26 April 2013.

ugent.be

biblio.ugent.be

Dhondt, Bert; De Bleser, Elise; Claeys, Tom; Buelens, Sarah; Lumen, Nicolaas; Vandesompele, Jo; Beckers, Anneleen; Fonteyne, Valerie; Van der Eecken, Kim (21 December 2018). "Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready for prime time". World Journal of Urology. 37 (12): 2557–2564. doi:10.1007/s00345-018-2609-8. PMID 30578441.

web.archive.org

Rhea, Jeanne; Ross J. Molinaro (March 2011). "Cancer Biomarkers: Surviving the journey from bench to bedside". Medical Laboratory Observer. Archived from the original on 14 October 2013. Retrieved 26 April 2013.
"Biomarkers in Cancer: An Introductory Guide for Advocates" (PDF). Research Advocacy Network. 2010. Archived from the original (PDF) on 2013-10-29. Retrieved 26 April 2013.
Lynch, TJ; Bell, DW; Sordella, R; Gurubhagavatula, S; Okimoto, RA; Brannigan, BW; Harris, PL; Haserlat, SM; Supko, JG (May 20, 2004). "Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib" (PDF). The New England Journal of Medicine. 350 (21): 2129–39. doi:10.1056/NEJMoa040938. PMID 15118073. Archived from the original (PDF) on 21 July 2018. Retrieved 7 April 2021.
Lemonick, Michael; Alice Park (May 28, 2001). "New Hope for Cancer". Time Magazine. Archived from the original on 25 April 2013. Retrieved 26 April 2013.
"Tumor Markers Fact Sheet" (PDF). American Cancer Society. Archived from the original (PDF) on 5 November 2012. Retrieved 7 April 2021.

worldcat.org

Herceg, Zdenko; Hainaut, Pierre (2007-06-01). "Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis". Molecular Oncology (به انگلیسی). 1 (1): 26–41. doi:10.1016/j.molonc.2007.01.004. ISSN 1878-0261. PMC 5543860. PMID 19383285.
Li, Danni; Chan, Daniel W. (2014-04-01). "Proteomic cancer biomarkers from discovery to approval: it's worth the effort". Expert Review of Proteomics. 11 (2): 135–136. doi:10.1586/14789450.2014.897614. ISSN 1478-9450. PMC 4079106. PMID 24646122.
Li, Xuanying; Ye, Mengsha; Zhang, Weiying; Tan, Duo; Jaffrezic-Renault, Nicole; Yang, Xu; Guo, Zhenzhong (2019-02-01). "Liquid biopsy of circulating tumor DNA and biosensor applications". Biosensors and Bioelectronics (به انگلیسی). 126: 596–607. doi:10.1016/j.bios.2018.11.037. ISSN 0956-5663. PMID 30502682.
Lapin, Morten; Oltedal, Satu; Tjensvoll, Kjersti; Buhl, Tove; Smaaland, Rune; Garresori, Herish; Javle, Milind; Glenjen, Nils Idar; Abelseth, Bente Kristin (2018-11-06). "Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer". Journal of Translational Medicine (به انگلیسی). 16 (1): 300. doi:10.1186/s12967-018-1677-2. ISSN 1479-5876. PMC 6218961. PMID 30400802.
Gupta, Digant; Lis, Christopher G. (2009-10-09). "Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literature". Journal of Ovarian Research. 2 (1): 13. doi:10.1186/1757-2215-2-13. ISSN 1757-2215. PMC 2764643. PMID 19818123.
Proctor, M J; McMillan, D C; Morrison, D S; Fletcher, C D; Horgan, P G; Clarke, S J (2012-07-24). "A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer". British Journal of Cancer. 107 (4): 695–699. doi:10.1038/bjc.2012.292. ISSN 0007-0920. PMC 3419948. PMID 22828611.
Liu, Man; Xing, Lu-Qi (2017-06-07). "Basic fibroblast growth factor as a potential biomarker for diagnosing malignant tumor metastasis in women". Oncology Letters. 14 (2): 1561–1567. doi:10.3892/ol.2017.6335. ISSN 1792-1074. PMC 5529833. PMID 28789380.
Fürstenberger, Gregor; Senn, Hans-Jörg (May 2002). "Insulin-like growth factors and cancer". The Lancet Oncology. 3 (5): 298–302. doi:10.1016/s1470-2045(02)00731-3. ISSN 1470-2045. PMID 12067807.
Yu, Herbert; Rohan, Thomas (2000-09-20). "Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression". JNCI: Journal of the National Cancer Institute (به انگلیسی). 92 (18): 1472–1489. doi:10.1093/jnci/92.18.1472. ISSN 0027-8874. PMID 10995803.
Vano, Yann-Alexandre; Oudard, Stéphane; By, Marie-Agnès; Têtu, Pauline; Thibault, Constance; Aboudagga, Hail; Scotté, Florian; Elaidi, Reza (2018-04-06). "Optimal cut-off for neutrophil-to-lymphocyte ratio: Fact or Fantasy? A prospective cohort study in metastatic cancer patients". PLOS ONE. 13 (4): e0195042. Bibcode:2018PLoSO..1395042V. doi:10.1371/journal.pone.0195042. ISSN 1932-6203. PMC 5889159. PMID 29624591.
Liu, Man; Xing, Lu-Qi (2017-08-01). "Basic fibroblast growth factor as a potential biomarker for diagnosing malignant tumor metastasis in women". Oncology Letters. 14 (2): 1561–1567. doi:10.3892/ol.2017.6335. ISSN 1792-1074. PMC 5529833. PMID 28789380.
Torrente-Rodríguez, Rebeca M.; Ruiz-Valdepeñas Montiel, Víctor; Campuzano, Susana; Pedrero, María; Farchado, Meryem; Vargas, Eva; Manuel de Villena, F. Javier; Garranzo-Asensio, María; Barderas, Rodrigo (2017-04-04). "Electrochemical sensor for rapid determination of fibroblast growth factor receptor 4 in raw cancer cell lysates". PLOS ONE. 12 (4): e0175056. Bibcode:2017PLoSO..1275056T. doi:10.1371/journal.pone.0175056. ISSN 1932-6203. PMC 5380347. PMID 28376106.
Denduluri, Sahitya K.; Idowu, Olumuyiwa; Wang, Zhongliang; Liao, Zhan; Yan, Zhengjian; Mohammed, Maryam K.; Ye, Jixing; Wei, Qiang; Wang, Jing (March 2015). "Insulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance". Genes & Diseases. 2 (1): 13–25. doi:10.1016/j.gendis.2014.10.004. ISSN 2352-3042. PMC 4431759. PMID 25984556.

zenodo.org

Ludwig, JA; Weinstein, JN (November 2005). "Biomarkers in cancer staging, prognosis and treatment selection". Nature Reviews Cancer. 5 (11): 845–56. doi:10.1038/nrc1739. PMID 16239904.
Verma, M; Manne, U (October 2006). "Genetic and epigenetic biomarkers in cancer diagnosis and identifying high risk populations". Critical Reviews in Oncology/Hematology. 60 (1): 9–18. doi:10.1016/j.critrevonc.2006.04.002. PMID 16829121.